Table 1.
Clinicopathological features of 16 large cell carcinomas (LCCs)
| ID | Age | Gender | Smoke | Mitosis (n) |
Necrosis | pT | pN | pM | Stage | FU (months) | Vital status | Cluster |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 71 | Female | Current | 36 | extended | 2 | 0 | 0 | I | 95 | DOD | LCC |
| 3 | 65 | Male | Current | 23 | extended | 2 | 0 | 0 | I | 2 | DOD | ADLike |
| 8 | 83 | Male | Current | 44 | spotted | 1 | 0 | 0 | I | 17 | DOD | LCC |
| 13 | 66 | Male | Current | 17 | extended | 1 | 1 | 1 | IV | 20 | DOD | LCC |
| 15 | 60 | Male | Former | 14 | absent | 2 | 0 | 0 | II | 45 | AWD | ADLike |
| 21 | 57 | Male | Current | 14 | absent | 1 | 0 | 0 | I | 17 | AWD | ADLike |
| 22 | 68 | Male | Former | 9 | extended | 1 | 2 | 0 | III | 13 | AWD | ADLike |
| 84 | 51 | Male | Current | 19 | extended | 1 | 0 | 0 | I | 242 | AWD | LCC |
| 87 | 66 | Male | Current | 39 | absent | 1 | 1 | 0 | II | 10 | DOD | LCC |
| 182 | 80 | Male | Former | 26 | extended | 2 | 0 | 0 | I | 48 | DOD | LCC |
| 294 | 70 | Male | Current | 42 | extended | 3 | 1 | 0 | III | 18 | AWD | LCC |
| 348 | 74 | Male | Current | 30 | spotted | 2 | 0 | 0 | I | 36 | DOD | LCC |
| 350 | 74 | Male | Never | 19 | extended | 2 | 0 | 0 | I | 24 | AWD | LCC |
| 494 | 77 | Male | Former | 43 | extended | 2 | 0 | 0 | I | 7 | DOD | LCC |
| VAL16 | 84 | Male | Current | 20 | extended | 1 | 0 | 0 | I | 15 | DOD | LCC |
| VAL26 | 60 | Male | Former | 11 | spotted | 2 | 0 | 0 | II | 25 | AWD | ADLike |
FU, follow up; DOD, dead of disease; AWD, alive without disease; cluster: according to transcription profile